These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6456074)

  • 21. Tolerance and suppressor T cells.
    Brent L
    Proc Eur Dial Transplant Assoc; 1977; 14():245-50. PubMed ID: 341124
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo and in vitro correlates of the specific transplantation tolerance induced by spontaneously tolerated liver allografts in inbred strains of rats.
    Houssin D; Charpentier B; Lang P; Tamisier D; Gugenheim J; Gigou M; Bismuth H
    Transplant Proc; 1981 Mar; 13(1 Pt 1):619-22. PubMed ID: 6455805
    [No Abstract]   [Full Text] [Related]  

  • 23. Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts.
    Slavin S; Reitz B; Bieber CP; Kaplan HS; Strober S
    J Exp Med; 1978 Mar; 147(3):700-7. PubMed ID: 147301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
    Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST
    Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 28. Induction of allograft tolerance with neonatal skin.
    Jamshidi F; De Fazio SR; Markees TG; Gozzo JJ
    Transplantation; 1991 May; 51(5):1048-52. PubMed ID: 2031261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of suppressor cells in transplantation tolerance.
    Tutschka PJ; Santos GW; Beschorner W
    Transplant Proc; 1979 Mar; 11(1):882-6. PubMed ID: 156436
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
    Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
    [No Abstract]   [Full Text] [Related]  

  • 31. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
    Thierfelder S; Rodt H
    Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment.
    Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M
    Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The male antigen in the rat.
    Heslop BF
    Transplantation; 1973 Jan; 15(1):31-5. PubMed ID: 4145725
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.
    Monaco AP; Gozzo JJ; Wood ML; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):680-3. PubMed ID: 4398509
    [No Abstract]   [Full Text] [Related]  

  • 38. Importance of natural killer cells in the rejection of hamster skin xenografts.
    Gourlay WA; Chambers WH; Monaco AP; Maki T
    Transplantation; 1998 Mar; 65(5):727-34. PubMed ID: 9521210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressor cells in transplantation tolerance. I. Analysis of the suppressor status of neonatally and adoptively tolerized rats.
    Dorsch S; Roser B
    Transplantation; 1982 May; 33(5):518-24. PubMed ID: 6211808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the mechanism of stable graft-host tolerance in canine and human radiation chimeras.
    Storb R; Tsoi MS; Weiden PL; Graham TC; Thomas ED
    Transplant Proc; 1976 Dec; 8(4):561-4. PubMed ID: 11587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.